Embedding an AI scribe moves four responsibilities onto your team that no integration guide covers. Your support desk takes the first call about a bad note. Your vendor's outage becomes your outage. You have to monitor note quality across clinicians you do not employ. And you cannot promise your customers more uptime than your vendor promises you.
Everything written about embedding a scribe stops at launch — build versus partner, integration architecture, who signs the Business Associate Agreement. This covers the part after that, which is where the cost actually shows up.
Your Support Desk Takes the First Call
The clinician using your product does not know your vendor exists. Under a white‑label arrangement they are not supposed to. So when a note comes back wrong, the ticket opens with you — and your tier‑one agent, who has never seen a transcription pipeline, has to decide whether this is a product bug, a capture problem, or a model limitation.
Three things worth settling before launch rather than during the first incident:
A Vendor Outage Is Your Outage
When the scribe is embedded, its failures are attributed to your brand. The clinician does not experience a vendor incident; they experience your product not working, in front of a patient.
The questions that matter are less about uptime percentages than about behaviour under failure:
- Is there a public status page, and does it reflect degradation or only total outages?
- How are incidents communicated to partners, through what channel, and how quickly?
- What are the degradation modes? If generation is down, does capture keep buffering locally and retry — or is the session lost?
- What is the historical incident record, not the advertised target?
That third question separates vendors more than any other. A tool that queues audio and retries when the service returns fails invisibly. A tool that drops the session fails in front of a patient, and your support desk hears about it. Ask for the specific behaviour, and test it during the pilot by pointing the integration at a dead endpoint.
Monitoring Quality Across Clinicians You Do Not Employ
You cannot read their notes. You may not have lawful access to them, and you should not want it. So quality monitoring has to run on signals that are not clinical content:
Signal | What it tells you | Watch for |
|---|---|---|
Regeneration rate | How often a clinician rejects the first draft outright | A rise after any vendor model change |
Edit rate or time-to-sign | How much work the draft still needs | Gradual drift, which is easy to miss month to month |
Abandonment | Sessions captured but never signed | Concentrations in one specialty or one capture mode |
Support ticket themes | What clinicians say when they bother to tell you | Repeated wording — the same complaint phrased three ways |
Per-specialty variance | Whether the aggregate is hiding a failure | One specialty performing far below the mean |
That last row is the one that catches teams out. A platform serving primary care, behavioural health and physical therapy can show a perfectly healthy overall edit rate while one specialty quietly performs badly enough that those customers are churning.
The SLA You Inherit, and the One You Can Offer
You cannot promise your customers more availability than your vendor promises you. That sounds obvious and is routinely violated, usually because the customer contract was drafted by a commercial team and the vendor contract by an engineering one.
Either match the vendor's terms in your own agreements, or carry the gap deliberately and price it. What to pin down:
- Availability commitment, and what remedy applies when it is missed — service credits are common and rarely meaningful.
- Notice period for breaking API changes, and how long deprecated versions keep working.
- Model changes. This is the one teams miss: a model update can change note style, length and structure overnight without a single API contract changing. Ask what notice you get and whether you can pin a version.
- Support response windows for your escalations, separately from end-user support.
The Incident Chain Runs Through You
Under the HIPAA Breach Notification Rule, a business associate must notify the covered entity of a breach without unreasonable delay and in no case later than 60 calendar days after discovery. Sixty days is a ceiling, not an allowance — "without unreasonable delay" is the operative standard.
The structural point for a platform: your vendor's duty runs to you, and your duty runs to your customers, who carry the public‑facing obligations to patients and to HHS. If your vendor's contractual window is the statutory maximum and your commitment to your customers is shorter, you have signed a gap you cannot close.
What to Settle Before You Sign
A short list, ordered by how expensive each is to fix after launch rather than before:
Question | Why it bites later |
|---|---|
Who answers the clinician's first call, and what can they see? | Support tooling is built early and rebuilt expensively |
What happens to an in-progress session when the service is down? | Determines whether outages are invisible or career-limiting |
What quality signals are exposed to us, through what interface? | You cannot baseline what you cannot read |
What notice do we get before a model change? | Note style can change with no API change at all |
What is the breach notification window in our BAA? | Sets whether your own customer commitments are keepable |
What availability are we contractually promised? | Caps what you can promise onward |
Bottom Line
The integration is the easy part, and it is the part everyone plans for. What determines whether an embedded scribe is a good decision eighteen months later is operational: who absorbs the support load, how the thing fails, whether you can see quality drift before your customers do, and whether the commitments you made onward are ones your vendor actually backs.
These are questions to put to any vendor, Twofold included. If a partner team cannot answer them specifically, that is itself the answer.